Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Imagine the bright side of life: A randomized controlled trial of two types of interpretation bias modification procedure targeting adolescent anxiety and depression.

de Voogd EL, de Hullu E, Burnett Heyes S, Blackwell SE, Wiers RW, Salemink E.

PLoS One. 2017 Jul 17;12(7):e0181147. doi: 10.1371/journal.pone.0181147. eCollection 2017.

2.

Using social and mobile tools for weight loss in overweight and obese young adults (Project SMART): a 2 year, parallel-group, randomised, controlled trial.

Godino JG, Merchant G, Norman GJ, Donohue MC, Marshall SJ, Fowler JH, Calfas KJ, Huang JS, Rock CL, Griswold WG, Gupta A, Raab F, Fogg BJ, Robinson TN, Patrick K.

Lancet Diabetes Endocrinol. 2016 Sep;4(9):747-55. doi: 10.1016/S2213-8587(16)30105-X. Epub 2016 Jul 14.

3.

Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study.

Hellem TL, Sung YH, Shi XF, Pett MA, Latendresse G, Morgan J, Huber RS, Kuykendall D, Lundberg KJ, Renshaw PF.

J Dual Diagn. 2015;11(3-4):189-202. doi: 10.1080/15504263.2015.1100471.

4.

Impact of enzalutamide on quality of life in men with metastatic castration-resistant prostate cancer after chemotherapy: additional analyses from the AFFIRM randomized clinical trial.

Cella D, Ivanescu C, Holmstrom S, Bui CN, Spalding J, Fizazi K.

Ann Oncol. 2015 Jan;26(1):179-85. doi: 10.1093/annonc/mdu510. Epub 2014 Oct 30.

5.

The HAPPY study (Holistic Approach to Pregnancy and the first Postpartum Year): design of a large prospective cohort study.

Truijens SE, Meems M, Kuppens SM, Broeren MA, Nabbe KC, Wijnen HA, Oei SG, van Son MJ, Pop VJ.

BMC Pregnancy Childbirth. 2014 Sep 8;14:312. doi: 10.1186/1471-2393-14-312.

6.
7.

Strategies for dealing with missing data in clinical trials: from design to analysis.

Dziura JD, Post LA, Zhao Q, Fu Z, Peduzzi P.

Yale J Biol Med. 2013 Sep 20;86(3):343-58. eCollection 2013 Sep. Review.

8.

Longitudinal missing data strategies for substance use clinical trials using generalized estimating equations: an example with a buprenorphine trial.

McPherson S, Barbosa-Leiker C, McDonell M, Howell D, Roll J.

Hum Psychopharmacol. 2013 Sep;28(5):506-15. doi: 10.1002/hup.2339. Review.

9.

The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors.

Grossberg GT, Manes F, Allegri RF, Gutiérrez-Robledo LM, Gloger S, Xie L, Jia XD, Pejović V, Miller ML, Perhach JL, Graham SM.

CNS Drugs. 2013 Jun;27(6):469-78. doi: 10.1007/s40263-013-0077-7.

10.

Mindfulness training for smoking cessation: moderation of the relationship between craving and cigarette use.

Elwafi HM, Witkiewitz K, Mallik S, Thornhill TA 4th, Brewer JA.

Drug Alcohol Depend. 2013 Jun 1;130(1-3):222-9. doi: 10.1016/j.drugalcdep.2012.11.015. Epub 2012 Dec 21.

11.

Self-report and clinician-rated measures of depression severity: can one replace the other?

Uher R, Perlis RH, Placentino A, Dernovšek MZ, Henigsberg N, Mors O, Maier W, McGuffin P, Farmer A.

Depress Anxiety. 2012 Dec;29(12):1043-9. doi: 10.1002/da.21993. Epub 2012 Aug 29.

12.

Submitted for your consideration: potential advantages of a novel clinical trial design and initial patient reaction.

Loop MS, Frazier-Wood AC, Thomas AS, Dhurandhar EJ, Shikany JM, Gadbury GL, Allison DB.

Front Genet. 2012 Aug 8;3:145. doi: 10.3389/fgene.2012.00145. eCollection 2012.

13.
14.

A randomised controlled trial of a self-management education program for osteoarthritis of the knee delivered by health care professionals.

Coleman S, Briffa NK, Carroll G, Inderjeeth C, Cook N, McQuade J.

Arthritis Res Ther. 2012 Jan 27;14(1):R21. doi: 10.1186/ar3703.

15.

Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder.

Gertsik L, Poland RE, Bresee C, Rapaport MH.

J Clin Psychopharmacol. 2012 Feb;32(1):61-4. doi: 10.1097/JCP.0b013e31823f3b5f.

16.

Remission with venlafaxine extended release or selective serotonin reuptake inhibitors in depressed patients: a randomized, open-label study.

Thase ME, Ninan PT, Musgnung JJ, Trivedi MH.

Prim Care Companion CNS Disord. 2011;13(1). pii: PCC.10m00979. doi: 10.4088/PCC.10m00979blu.

18.

Symptom improvement and residual symptoms during acute antidepressant treatment in pediatric major depressive disorder.

Tao R, Emslie GJ, Mayes TL, Nakonezny PA, Kennard BD.

J Child Adolesc Psychopharmacol. 2010 Oct;20(5):423-30. doi: 10.1089/cap.2009.0116.

19.

Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial.

Holroyd KA, Cottrell CK, O'Donnell FJ, Cordingley GE, Drew JB, Carlson BW, Himawan L.

BMJ. 2010 Sep 29;341:c4871. doi: 10.1136/bmj.c4871.

20.

A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia.

Chappell AS, Bradley LA, Wiltse C, Detke MJ, D'Souza DN, Spaeth M.

Int J Gen Med. 2008 Nov 30;1:91-102.

Supplemental Content

Support Center